Moderna and Lonza announced worldwide strategic collaboration to manufacture Moderna’s Vaccine (mRNA-1273) against novel Coronavirus
| | | | |

Moderna and Lonza announced worldwide strategic collaboration to manufacture Moderna’s Vaccine (mRNA-1273) against novel Coronavirus

On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…

Sarepta Therapeutics announced research agreement with U.S. DoD to evaluate multiple constructs from proprietary RNA platform as treatments for COVID-19
| | | |

Sarepta Therapeutics announced research agreement with U.S. DoD to evaluate multiple constructs from proprietary RNA platform as treatments for COVID-19

On Apr. 28, 2020, Sarepta Therapeutics announced the Company and the USAMRIID, the Department of Defense’s lead laboratory…